业已证实尿毒症患者有免疫功能紊乱,特别是细胞免疫功能低下,透析疗法能明显改善患者的免疫机能,本文目的在于探讨尿毒症非透析及透析患者红细胞免疫功能变化。材料与方法:选择尿毒症终末期患者共30例,原发病均为慢性肾小球肾炎,BUN>21.42mmol/L(60.0mg/dl),Cr>442.01μmol/L(5mg/dl)。 Uremia has been confirmed in patients with immune dysfunction, especially cellular immune dysfunction, dialysis therapy can significantly improve the patient’s immune function, the purpose of this paper is to investigate uremic non-dialysis and dialysis patients with red blood cell immune function changes. MATERIALS AND METHODS: Thirty patients with end-stage uremia were selected. The primary disease was chronic glomerulonephritis with BUN> 21.42mmol / L (60.0mg / dl) and Cr> 442.01μmol / L (5mg / dl).